angiotensin ii has been researched along with dihydropyridines in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (4.76) | 18.7374 |
1990's | 27 (42.86) | 18.2507 |
2000's | 19 (30.16) | 29.6817 |
2010's | 14 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marks, AR | 1 |
Fujishima, M; Fujita, S; Hirakata, H; Iino, K; Ishida, I; Kashiwagi, M; Okuda, S; Yoshinari, M | 1 |
Higaki, J; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T; Tomita, N; Yu, H | 1 |
Fukiyama, K; Kawazoe, N; Muratani, H; Takishita, S; Tozawa, M | 1 |
Creager, MA; Cutler, SS; Dzau, VJ; Hirsch, AT; Levenson, DJ | 1 |
Ambroz, C; Catt, KJ | 1 |
Hisa, H; Satoh, S; Suzuki-Kusaba, M; Takahara, A | 1 |
Gandhi, V; Hester, RK; Hojo, M; Jino, H; Jones, DJ; Kodama, I; Satake, N; Shibata, S; Tatsumi, H; Wang, CG | 1 |
Catt, KJ; Hausdorff, WP | 1 |
Bonvallet, R; Rougier, O | 1 |
Hamajo, K; Nagaoka, A; Shibota, M | 1 |
Bagó, A; Deák, F; Hunyady, L; Rohács, T; Spät, A | 1 |
Elliott, HL | 2 |
Bauer, J; Knaus, J; Luger, A; Reams, G; Villareal, D; Wu, Z | 1 |
Bauer, JH; Luger, AM; Reams, GP; Villarreal, D; Wang, X; Wu, Z | 1 |
Demura, H; Hagiwara, H; Hirose, S; Muraki, T; Naruse, K; Naruse, M; Shionoya, K; Tanabe, A; Tanaka, M; Yoshimoto, T | 1 |
Arnaudeau, S; Macrez-Leprêtre, N; Mironneau, J | 1 |
Balla, T; Catt, KJ; Rössig, L; Zólyomi, A | 1 |
Chatani, F; Sato, K; Sato, S | 1 |
Enyedi, P; Horváth, A; Rohács, T; Spät, A; Szabadkai, G | 1 |
Inada, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Wada, T | 1 |
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Pinto, Y; Schiffer, F; Stasch, JP; Zolk, O | 1 |
Dohmoto, H; Hisa, H; Satoh, S; Takahara, A; Yoshimoto, R | 1 |
Beuck, M; Dressel, J; Fey, P; Frobel, K; Hirth-Dietrich, C; Hübsch, W; Kazda, S; Knorr, A; Krämer, T; Sander, E; Stasch, JP | 1 |
Belz, GG; Breithaupt-Grögler, K; Butzer, R; Herrmann, V; Malerczyk, C; Stass, H; Wensing, G | 1 |
Coyne, MD; Lemos, JR; Rodriguez, O; Wang, G; Wilson, Y | 1 |
Aso, T; Bronson, RA; Kubota, T; Maruyama, Y; Shimizu, Y; Yorimitsu, A | 1 |
Donnelly, R; Elliott, HL; Morris, AD; Panfilov, V; Ueda, S | 1 |
Iouzalen, L; Marche, P; Stepien, O | 1 |
Eto, T; Imamura, T; Kato, J; Kitamura, K; Koiwaya, Y; Matsuo, T; Onitsuka, H; Tsumori, Y; Yamakawa, H | 1 |
Garcha, RS; Hughes, AD; Sever, PS | 1 |
Leenen, FH; Zhang, J | 1 |
Balt, JC; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA | 1 |
Barbot, C; Bondeva, T; Henaff, M; Le Blanc, C; Macrez, N; Mironneau, C; Wetzker, R | 1 |
Cui, TX; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Suzuki, J; Tsuda, M | 1 |
Berkels, R; Breitenbach, T; Drummond, G; Lob, H; Roesen, R; Rosenkranz, AC | 1 |
Abe, Y; Hara, T; Hitomi, H; Kimura, S; Kiyomoto, H; Kohno, M; Kondo, N; Miyatake, A; Moriwaki, K; Nishiyama, A; Rahman, M; Sun, GP; Yamamoto, T | 1 |
Inoue, H; Kikuchi, S; Matsui, T; Nakamura, K; Yamagishi, S | 1 |
Agrawal, R; Bahlmann, FH; Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT; Kirsch, T; Lindschau, C; Marx, A; Meier, M; Menne, J; Muller, D; Park, JK | 1 |
Enomoto, A; Konda, T; Takahara, A; Yamamoto, H | 1 |
Horii, M; Imagawa, K; Iwama, H; Kawata, H; Nakajima, T; Naya, N; Okayama, S; Saito, Y; Somekawa, S; Uemura, S | 1 |
Akizuki, O; Inayoshi, A; Kitayama, T; Kusaka, H; Matsubara, M; Sasaki, K; Shirakura, S; Yao, K | 1 |
Endoh, M | 1 |
Ikeda, K; Inada, Y; Isaka, T; Tajima, N; Takada, Y; Tojo, K | 1 |
Aritomi, S; Enomoto, A; Koganei, H; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
Fujimoto, S; Horike, H; Kashihara, N; Nagasu, H; Sasaki, T; Satoh, M | 1 |
Geot, WM; Horikoshi, S; Suzuki, Y; Takahashi, H; Tanifuji, C; Tomino, Y | 1 |
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H | 1 |
Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Nakamura, H; Wakahara, S | 1 |
Aritomi, S; Konda, T; Mitsui, A; Mori, Y; Nogi, Y; Numata, T; Uriu, Y; Wagatsuma, H; Yoshimura, M | 1 |
Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
Ikeda, K; Saito, T; Tojo, K | 1 |
Horiguchi, N; Ichikawa, T; Izumi, T; Kakizaki, S; Kishimoto, K; Mori, M; Ohyama, T; Sato, K; Takagi, H; Yamazaki, Y | 1 |
Aritomi, S; Konda, T; Yoshimura, M | 1 |
Chang, CJ; Dickinson, BC; Guo, Q; Hu, C; Ito, S; Lu, Y; Miyata, T; Mori, T; Nakamichi, T; Oba, I; Ogawa, S; Ohsaki, Y; Sato, E; Sato, H; Sun, Y; Yoneki, Y | 1 |
Asanuma, K; Fujisawa, Y; Hitomi, H; Kobori, H; Lei, B; Liu, Y; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Tomino, Y | 1 |
Hirata, Y; Kitagawa, T; Kurobe, H; Matsuoka, Y; Maxfield, MW; Sata, M; Sugasawa, N | 1 |
Aritomi, S; Harada, E; Hirano, K; Ishikawa, T; Kim-Mitsuyama, S; Kuwahara, K; Mori, Y; Nishida, M; Saiki, S; Sunggip, C | 1 |
Özcan, EE; Özel, E; Öztürk, A; Senaslan, Ö; Uyar, S | 1 |
Enyeart, JA; Enyeart, JJ | 1 |
Jiang, D; Kato, J; Kawagoe, Y; Kitamura, K; Kuwasako, K | 1 |
Chen, Y; Jiang, G; Lv, Q; Yuan, J; Zhu, J; Zou, Y | 1 |
3 review(s) available for angiotensin ii and dihydropyridines
Article | Year |
---|---|
Calcium channels expressed in vascular smooth muscle.
Topics: Amino Acid Sequence; Angiotensin II; Calcium; Calcium Channels; Cell Membrane; Dihydropyridines; DNA; Gene Expression; Gene Expression Regulation; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Intracellular Fluid; Muscle Contraction; Muscle, Smooth, Vascular; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 1992 |
Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cardiovascular Physiological Phenomena; Cardiovascular System; Dihydropyridines; Humans; Hypertension; Norepinephrine; Vascular Resistance; Vasoconstriction | 1993 |
Cardiac Ca2+ signaling and Ca2+ sensitizers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Azocines; Calcium; Calcium Signaling; Cardiotonic Agents; Cholinergic Agonists; Dihydropyridines; Endothelins; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Quinolines; Simendan; Thiadiazines; Troponin C | 2008 |
6 trial(s) available for angiotensin ii and dihydropyridines
Article | Year |
---|---|
Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Dihydropyridines; Endothelins; Female; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Renal Circulation | 1992 |
Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Hemodynamics; Humans; Hypertension; Isradipine; Male; Middle Aged; Norepinephrine; Pressoreceptors; Reflex; Regional Blood Flow | 1992 |
Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Humans; Infusions, Intravenous; Male; Regression Analysis; Tetrazoles; Vasoconstrictor Agents | 1997 |
Lacidipine: effects on vascular pressor responses throughout the dosage interval in normotensive subjects.
Topics: Adult; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Exanthema; Humans; Male; Norepinephrine; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Calcium Channel Blockers; Calcium Channels, T-Type; Cross-Over Studies; Depression, Chemical; Dihydropyridines; Hemodynamics; Humans; Male; Neurotransmitter Agents; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renin; Water-Electrolyte Balance | 2006 |
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin I; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System | 2010 |
54 other study(ies) available for angiotensin ii and dihydropyridines
Article | Year |
---|---|
Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Abdominal; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Hydralazine; Hypertension; Hypertrophy; Indans; Male; Nitrobenzenes; Piperazines; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1992 |
Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
Topics: Air Pressure; Angiotensin II; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Dihydropyridines; Endothelins; Heart Rate; Hypertension; Infusions, Intravenous; Injections, Intraventricular; Kidney; Male; Natriuresis; Nitrobenzenes; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sodium; Stress, Physiological; Stress, Psychological; Time Factors | 1992 |
Angiotensin II receptor-mediated calcium influx in bovine adrenal glomerulosa cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Calcium; Calcium Channels; Cattle; Cells, Cultured; Dihydropyridines; GTP-Binding Proteins; Imidazoles; Lanthanum; Losartan; Pertussis Toxin; Receptors, Angiotensin; Tetrazoles; Virulence Factors, Bordetella; Zona Glomerulosa | 1992 |
Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Gallic Acid; Heart Rate; Male; Renal Circulation; Vasoconstriction; Vasopressins | 1990 |
Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
Topics: Action Potentials; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Female; Guinea Pigs; Heart; Histamine; In Vitro Techniques; Lanthanum; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Nifedipine; Norepinephrine; Potassium; Rabbits; Serotonin | 1991 |
Activation of dihydropyridine-sensitive calcium channels and biphasic cytosolic calcium responses by angiotensin II in rat adrenal glomerulosa cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium; Calcium Channels; Cattle; Cytosol; Dihydropyridines; Ethers; Ionomycin; Kinetics; Male; Nifedipine; Potassium; Rats; Rats, Inbred Strains; Species Specificity; Spectrometry, Fluorescence; Zona Glomerulosa | 1988 |
Existence of two calcium currents recorded at normal calcium concentrations in single frog atrial cells.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Barium; Calcium; Calcium Channel Blockers; Dihydropyridines; Heart Atria; In Vitro Techniques; Membrane Potentials; Rana esculenta; Strontium; Time Factors | 1989 |
Effects of a new dihydropyridine derivative, CV-4093.2HCl, on renal hemodynamics in spontaneously hypertensive rats.
Topics: Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Nicardipine; Nitrobenzenes; Norepinephrine; Piperazines; Rats; Rats, Inbred SHR; Regional Blood Flow; Renal Circulation; Time Factors | 1989 |
Dihydropyridine-sensitive initial component of the ANG II-induced Ca2+ response in rat adrenal glomerulosa cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium; Calcium Channels, L-Type; Dihydropyridines; Female; Manganese; Membrane Potentials; Muscle Proteins; Nifedipine; Potassium; Rats; Rats, Wistar; Zona Glomerulosa | 1994 |
Vascular reactivity: a measurement of calcium channel blockade.
Topics: Amlodipine; Angiotensin II; Blood Pressure; Dihydropyridines; Humans; Infusions, Intravenous; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Vasoconstriction | 1995 |
Glomerular function and structure in the sodium-replete and sodium-deplete uninephrectomized spontaneously hypertensive rat: effect of blood pressure reduction, glomerular structure, and blood pressure reduction.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Dihydropyridines; Kidney Glomerulus; Male; Nephrectomy; Nitrobenzenes; Piperazines; Rats; Rats, Inbred SHR; Sodium, Dietary | 1995 |
An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Dihydropyridines; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Kidney; Male; Nephrectomy; Nitrobenzenes; Piperazines; Proteinuria; Rats; Rats, Inbred SHR | 1993 |
Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Down-Regulation; Guanylate Cyclase; Hypertension; Male; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Nitrobenzenes; Piperazines; Proteins; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles | 1996 |
Activation of calcium sparks by angiotensin II in vascular myocytes.
Topics: Angiotensin II; Animals; Calcium; Calcium Channels; Cells, Cultured; Dihydropyridines; Ion Channel Gating; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Portal Vein; Rats; Rats, Wistar; Receptors, Angiotensin | 1996 |
Regulation of angiotensin II-stimulated Ca2+ oscillations by Ca2+ influx mechanisms in adrenal glomerulosa cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium; Calcium Channels; Cattle; Dihydropyridines; Dose-Response Relationship, Drug; Evoked Potentials; Inositol Phosphates; Nifedipine; Terpenes; Thapsigargin; Zona Glomerulosa | 1996 |
Role of angiotensin II in reflex tachycardia during hypotension caused by a calcium channel blocker.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Enalapril; Hemodynamics; Hypotension; Nitrobenzenes; Piperazines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Tachycardia; Tachycardia, Sinus; Telemetry; Tetrazoles; Time Factors | 1996 |
The role of voltage-dependent calcium channels in angiotensin-stimulated glomerulosa cells.
Topics: Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Radioisotopes; Cytoplasm; Dihydropyridines; Diltiazem; Electrophysiology; Inositol 1,4,5-Trisphosphate Receptors; Manganese; Membrane Potentials; Potassium; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Zona Glomerulosa | 1996 |
Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Hydrochlorothiazide; Male; Nitrobenzenes; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Blotting, Western; Calcium-Transporting ATPases; Captopril; Cardiomyopathy, Hypertrophic; Diastole; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Mice; Mice, Transgenic; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Tetrazoles | 1997 |
Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogs.
Topics: Anesthesia; Angiotensin II; Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Kidney; Male; Natriuresis; Norepinephrine; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Cerebrovascular Disorders; Cyclic GMP; Dihydropyridines; Hemodynamics; Hormones; Hypertension; Kidney; Rats; Rats, Inbred SHR; Renin; Tetrazoles | 1997 |
Voltage dependent calcium and potassium currents in Y-1 adrenocortical cells are unresponsive to ACTH.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electric Stimulation; Electrophysiology; Mice; omega-Conotoxin GVIA; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels; Tumor Cells, Cultured | 1997 |
Prostaglandins induce calcium influx in human spermatozoa.
Topics: Acrosome; Adult; Alprostadil; Angiotensin II; Atrial Natriuretic Factor; Body Fluids; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Media; Cyclic AMP; Dihydropyridines; Dinoprost; Dinoprostone; Drug Interactions; Endothelin-1; Female; Humans; Infertility, Male; Ion Transport; Male; Ovarian Follicle; Pentoxifylline; Pertussis Toxin; Progesterone; Sperm Capacitation; Sperm-Ovum Interactions; Spermatozoa; Virulence Factors, Bordetella | 1998 |
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles | 1999 |
Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload.
Topics: Adrenomedullin; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diastole; Dihydropyridines; Gene Expression; Heart Rate; Hypertrophy, Left Ventricular; Male; Nitrobenzenes; Peptides; Piperazines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Stress, Mechanical; Tetrazoles; Vasoconstrictor Agents | 2000 |
Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries.
Topics: Amlodipine; Angiotensin II; Arteries; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Flavonoids; Genistein; Humans; In Vitro Techniques; Nickel; Norepinephrine; Potassium; Ryanodine; Skin; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Peripheral Nervous System; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles | 2001 |
Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Topics: Acrylates; Adrenergic alpha-Agonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dihydropyridines; Dose-Response Relationship, Drug; Imidazoles; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Thiophenes; Valine; Valsartan | 2001 |
Regulation of vascular L-type Ca2+ channels by phosphatidylinositol 3,4,5-trisphosphate.
Topics: Androstadienes; Angiotensin II; Animals; Barium; Calcium; Calcium Channels, L-Type; Calmodulin-Binding Proteins; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Cytosol; Dihydropyridines; Enzyme Inhibitors; Ion Channel Gating; Ion Transport; Isoenzymes; Lipid Metabolism; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nerve Tissue Proteins; Neurogranin; Patch-Clamp Techniques; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Portal Vein; Protein Processing, Post-Translational; Rats; Rats, Wistar; Recombinant Fusion Proteins; Substrate Specificity; Transfection; Wortmannin | 2004 |
Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Azetidinecarboxylic Acid; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley | 2005 |
Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Calcium Channel Blockers; Cell Line; Dihydropyridines; Endothelial Cells; Humans; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Protein Kinase C; Superoxides | 2006 |
Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Ischemia; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Vascular Resistance | 2006 |
Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
Topics: Angiotensin II; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Endothelial Cells; Eye Proteins; Gene Expression Regulation; Humans; Microcirculation; Nerve Growth Factors; Nitrendipine; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Serpins | 2005 |
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers.
Topics: Albumins; Amidohydrolases; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arginine; Calcium Channel Blockers; Dihydropyridines; Gene Expression Regulation, Enzymologic; Hypertension; Kidney; Rats; Rats, Sprague-Dawley; Renin | 2006 |
Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Disease Progression; Hemodynamics; Hypertension; Kidney; Kidney Cortex; Kidney Failure, Chronic; Kidney Function Tests; Male; Norepinephrine; Rats; Rats, Inbred Dahl; Renin; von Willebrand Factor | 2006 |
Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line; Cytochrome P-450 CYP11B2; Dihydropyridines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Membrane Potentials; Patch-Clamp Techniques; Potassium Chloride; RNA, Messenger; Steroid 11-beta-Hydroxylase; Tetrazoles; Valine; Valsartan | 2008 |
Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Azetidinecarboxylic Acid; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Dihydropyridines; Gene Expression Regulation; Humans; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Steroid 11-beta-Hydroxylase | 2009 |
Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Conotoxins; Dihydropyridines; Humans; Male; Norepinephrine; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Time Factors | 2009 |
Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.
Topics: Angiotensin II; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Infusions, Intravenous; Male; Microcirculation; Nephritis, Interstitial; Nifedipine; Rats; Rats, Wistar; Renal Circulation | 2009 |
Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Blotting, Western; Calcium Channel Blockers; Dihydropyridines; Drug Synergism; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Imidazoles; Immunohistochemistry; Kidney; Mice; NADPH Oxidases; Nitric Oxide Synthase Type III; Polycystic Kidney Diseases; Tetrazoles | 2009 |
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors | 2009 |
Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Angiotensin II; Barium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium Signaling; Cell Line; Cytochrome P-450 CYP11B2; Dihydropyridines; Humans; omega-Conotoxins; Steroid 11-beta-Hydroxylase | 2011 |
Effects of an N-type calcium antagonist on angiotensin II-renin feedback.
Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Male; Models, Biological; Rats; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2011 |
Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
Topics: Adrenocortical Carcinoma; Angiotensin II; Bucladesine; Calcium Channel Blockers; Cell Line, Tumor; Dehydroepiandrosterone Sulfate; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Nitrophenols; Organophosphorus Compounds; Phosphoproteins; RNA, Messenger; Verapamil | 2011 |
Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.
Topics: Angiotensin II; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium; Calcium Channel Blockers; Carbon Tetrachloride; Cell Line; Cell Survival; Collagen Type I; Collagen Type I, alpha 1 Chain; Dihydropyridines; Disease Models, Animal; Gene Expression Regulation; Humans; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; RNA, Messenger; Thioacetamide; Transforming Growth Factor beta1 | 2012 |
L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Disease Models, Animal; Down-Regulation; Hypertension; Injections, Intravenous; Male; Nifedipine; Rats; Rats, Inbred SHR; Reflex; Renin-Angiotensin System | 2012 |
Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Disease Models, Animal; Drug Antagonism; Infusions, Intravenous; Ischemia; Kidney Medulla; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitrogen Dioxide; Nitrogen Oxides; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstrictor Agents | 2012 |
N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cell Line; Desmin; Dihydropyridines; Hypertension; Male; Mice; Podocytes; Protective Agents; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System | 2012 |
Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
Topics: Aminopropionitrile; Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Inflammation Mediators; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Sirtuin 1; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice.
Topics: Amlodipine; Angiotensin II; Animals; Aorta, Thoracic; Biomarkers; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Hypertension; Macrophages; Mice; omega-Conotoxin GVIA; Oxidative Stress; Reactive Oxygen Species; Vasodilation; Vasodilator Agents | 2013 |
Medical treatment of an adult with uncorrected isolated interrupted aorta resulted in no complications after 4 years of follow-up.
Topics: Angiography; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Aorta, Thoracic; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Irbesartan; Middle Aged; Multidetector Computed Tomography; Tetrazoles; Time Factors; Vascular Malformations | 2014 |
Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion.
Topics: Action Potentials; Adrenocorticotropic Hormone; Angiotensin II; Animals; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cattle; Cyclic AMP; Dihydropyridines; Fluspirilene; Gene Expression; Hydrocortisone; Microelectrodes; Nifedipine; Patch-Clamp Techniques; Penfluridol; Pimozide; Piperidines; Protein Isoforms; Single-Cell Analysis; Zona Fasciculata | 2015 |
Inhibitory effects of losartan and azelnidipine on augmentation of blood pressure variability induced by angiotensin II in rats.
Topics: Angiotensin II; Animals; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Hypertension; Losartan; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Time Factors | 2017 |
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction | 2017 |